Back to Selection     Print       Date : 30 Jun 2025
Fund Summary
Mahindra Manulife Focused Fund Reg (G)
[Equity: Focused]  
 
Fund Details
Fund Type Growth Launch Date 17-Nov-2020
Corpus(Cr.) 2186.0 Latest NAV 26.808 As on 17-07-2025
Equity(%) 97.93 52 Week High 28.3813
Debt(%) 2.07 52 Week Low 23.5493
Others(%) 0.0 Exit Load -
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.97
Scheme Benchmark NIFTY 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Fatema Pacha
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of maximum 30 companies across market capitalisation.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 30.20%
Top 10 Holdings 51.03%
Top 25 Holdings 90.05%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 21.72
Construction 10.81
Software & Services 8.09
Oil & GAS 7.33
FMCG 6.97
Petroleum Products 6.86
Finance & Investments 5.3
Automobile 4.96
Telecom 4.94
Pharma & Biotech 4.29
Energy 3.22
Retail 2.79
Consumer Durables 2.43
Electricals 2.38
Cash 2.07
SERVICES 1.95
Ferrous Metals 1.76
Paper 1.49
Agricultural & Farm Machinery 0.64
 
 
 
 
 
Portfolio Metrics
PB Ratio 2.87
PE Ratio 19.16
 
Top 25 Holdings
Holdings Net Asset(%)
HDFC Bank Limited 7.00
Reliance Industries Limited 6.86
ICICI Bank Limited 6.05
State Bank of India 5.35
Indus Towers Limited 4.94
Infosys Limited 4.54
Grasim Industries Limited 4.34
Larsen & Toubro Limited 4.26
ITC Limited 4.14
Tech Mahindra Limited 3.55
KOTAK MAHINDRA BANK LTD.-31-Jul-2025 3.32
Bajaj Finance Limited 3.26
NTPC Limited 3.22
Hindustan Unilever Limited 2.83
Trent Limited 2.79
GAIL ( INDIA ) LTD 2.55
Hero MotoCorp Limited 2.52
Maruti Suzuki India Limited 2.44
Whirlpool of India Limited 2.43
Coal India Limited 2.42
Siemens Energy India Limited 2.38
OIL & NATURAL GAS CO. 2.36
The Ramco Cements Limited 2.21
Sun Pharmaceutical Industries Limited 2.18
Biocon Limited 2.11

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
1.59% 5.75% 7.58% -1.25%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.27% 5.85% 8.97% 3.25%
 
Scheme Benchmark [NSE - Nifty 500 TRI]
2.08% 8.44% 8.60% 1.89%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
22.78% 23.48% 0.00% 0.00%
 
 
14.22% 17.38% 19.56% 12.65%
 
 
18.93% 20.38% 22.59% 13.84%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection